Welcome to our dedicated page for Ecolab SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
Ecolab Inc. director Michael Larson received a grant of 732 Non-Employee Director Stock Options linked to 732 shares of common stock. The options have an exercise price of $247.7000 per share and expire on May 15, 2036. They vest 25% at the end of each of the first three three-month periods after the grant date, with the remaining shares vesting on the earlier of the end of the fourth three-month period or the company’s next annual meeting. The options become fully exercisable if a Change in Control occurs. Following these transactions, Larson directly holds 19,007.5 shares of Ecolab common stock.
Ecolab Inc. director Marion K. Gross reported a new grant of non-employee director stock options. She received options for 732 shares of common stock at an exercise price of $247.70 per share, expiring on May 15, 2036.
The options begin vesting on August 15, 2026, with 25% of the shares vesting at the end of each of the first three three-month periods after grant and the remainder vesting on the earlier of the end of the fourth three-month period or the company’s next annual meeting. The filing also shows she directly holds 466.0100 shares of common stock after the reported transactions.
Ecolab Inc. director Eric Mark Green received a new stock option grant as part of his board compensation. He was awarded options for 732 shares of common stock at an exercise price of $247.7000 per share, with no cash paid at grant.
The options vest in stages: 25% of the shares on the last day of each of the first three three-month periods after the grant date, and the remaining shares on the earlier of the last day of the fourth three-month period or the company’s next annual meeting date. All options become fully exercisable if a defined Change in Control of the company occurs.
Following these updates, Green directly holds 3,973.5100 shares of Ecolab common stock and 732 stock options, reflecting routine equity-based compensation rather than an open-market purchase or sale.
ECOLAB INC. director Michel D. Doukeris reported a new stock option grant and updated share holdings. He received a grant of 732 Non-Employee Director Stock Options, each covering one share of Common Stock, with an exercise price of 247.7000 and expiration on 2036-05-15.
The option vests in stages: 25% of the option shares on the last day of each of the first three three‑month periods after the grant date, and the remaining shares on the last day of the fourth three‑month period or the company’s next annual meeting date, whichever is earlier. The first vesting date is listed as 2026-08-15.
Following these updates, Doukeris is shown holding 576.2600 shares of Ecolab Common Stock directly, and 732.0000 director stock options tied to an equal number of underlying Common Stock shares.
Ecolab Inc. director Shari L. Ballard received a grant of 732 Non-Employee Director Stock Options with an exercise price of $247.70 per share, each option tied to one share of common stock. The options begin vesting on August 15, 2026, with 25% vesting at the end of each of the first three three-month periods after the grant and the balance vesting at the earlier of the end of the fourth three-month period or the company’s next annual meeting date. The options become fully exercisable immediately if a Change in Control, as defined in the company’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, occurs. Following these transactions, Ballard directly holds 9,400.11 shares of Ecolab common stock and 732 stock options.
Ecolab Inc. director Judson Althoff reported a routine equity compensation grant. He received 732 Non-Employee Director Stock Options for Common Stock at an exercise price of $247.70 per share, expiring on May 15, 2036, with quarterly vesting. Following these transactions, he directly holds 1,139.93 shares of Ecolab common stock.
Ecolab Inc. is offering multiple series of senior unsecured notes, including a Compounded SOFR‑linked floating rate series and several fixed‑rate series, issued only in registered global form.
The company intends to use a portion of net proceeds to fund its pending acquisition of CoolIT Systems for approximately $4.75 billion, subject to customary closing conditions and regulatory approvals. If the acquisition is not completed by the Special Mandatory Redemption End Date (no earlier than September 16, 2026) or the merger agreement is terminated earlier, Ecolab must redeem certain series (the "SMR notes") at a special mandatory redemption price equal to 101% of principal plus accrued interest.
ECOLAB INC. director David MacLennan reported an open-market purchase of 1,000 shares of Common Stock at $250.65 per share. Following this buy, he directly holds 25,230.01 shares. He also reports indirect holdings of 709 shares through sibling's trusts and 3,500 shares through a revocable trust.
Ecolab Inc. reported leadership and governance updates. The board elected Bryce L. Mewhorter as Senior Vice President and Corporate Controller and designated him as principal accounting officer, effective the day after Ecolab files its Form 10-Q for the second quarter of 2026. He will move into this role from his current position leading finance for Global Water, and will participate in the company’s regular executive compensation programs.
Ecolab also released results from its 2026 Annual Meeting of Stockholders. At the record date of March 10, 2026, the company had 282,423,768 common shares outstanding, and 254,343,064 shares were represented at the meeting. Stockholders elected 13 directors for one-year terms, approved on an advisory basis the compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026. A stockholder proposal for an independent board chair policy did not receive approval.
Ecolab delivered higher first‑quarter 2026 results, with net sales of $4,066.1 million up from $3,695.0 million and net income attributable to Ecolab rising to $432.6 million from $402.5 million. Diluted EPS increased to $1.52 from $1.41.
Operating income grew to $622.0 million, helped by stronger product and service sales across Global Water, Institutional & Specialty, Pest Elimination and Life Sciences. Cash provided by operating activities improved to $445.9 million. Ecolab also advanced its One Ecolab restructuring and integration of the $1,595.7 million Ovivo Electronics acquisition, and agreed to acquire CoolIT Systems for $4.75 billion, supported by a matching committed term loan facility.